NCT06112509 Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
| NCT ID | NCT06112509 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Besancon |
| Condition | Vestibular Schwannoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-02-20 |
| Primary Completion | 2024-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-02-20 with a primary completion date of 2024-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the vestibular effects of gamma-knife radiosurgery, as part of the treatment of vestibular schwannoma.
Eligibility Criteria
Inclusion Criteria : * Men and women aged 18 to 90 included * Subject who benefited from gamma-knife radiosurgery as part of the treatment of vestibular schwannoma * Non-opposition of the subject to participate in the study * Affiliation to a French social security scheme or beneficiary of such a scheme Exclusion Criteria : * Subject with another vestibular pathology * Subject who did not benefit from a vestibular assessment before treatment with gamma-knife radiosurgery * Legal incapacity or limited legal capacity * Subject unlikely to cooperate in the study and/or weak cooperation anticipated by the investigator * Subject without health insurance * Subject being in the period of exclusion from another study or provided for by the "national volunteer file".
Contact & Investigator
DAMON Veronique, MD
PRINCIPAL INVESTIGATOR
CHU de Besançon
Frequently Asked Questions
Who can join the NCT06112509 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Vestibular Schwannoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06112509 currently recruiting?
Yes, NCT06112509 is actively recruiting participants. Contact the research team at mabisse@chu-besancon.fr for enrollment information.
Where is the NCT06112509 trial being conducted?
This trial is being conducted at Besançon, France.
Who is sponsoring the NCT06112509 clinical trial?
NCT06112509 is sponsored by Centre Hospitalier Universitaire de Besancon. The principal investigator is DAMON Veronique, MD at CHU de Besançon. The trial plans to enroll 20 participants.